Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience (Q37701881)
Jump to navigation
Jump to search
scientific article published on 02 August 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience |
scientific article published on 02 August 2013 |
Statements
1 reference
Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience (English)
1 reference
Keith T Flaherty
1 reference
Jedd D Wolchok
1 reference
F Stephen Hodi
1 reference
Anita Giobbie-Hurder
1 reference
Sandra D'Angelo
1 reference
Nageatte Ibrahim
1 reference
Michael A Postow
1 reference
Nikhil Ramaiya
1 reference
Jason J Luke
1 reference
Margaret K Callahan
1 reference
Emanuela Romano
1 reference
Mark Bluth
1 reference
Donald P Lawrence
1 reference
Patrick A Ott
1 reference
Ryan J Sullivan
1 reference
James J Harding
1 reference
Mark Dickson
1 reference
Gary K Schwartz
1 reference
Paul B Chapman
1 reference
Richard D Carvajal
1 reference
2 August 2013
1 reference
1 reference
3687-3695
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference